Retraction Note to: British Journal of Cancer https://doi.org/10.1038/bjc.2013.153, published online 09 April 2013
The Editor-in-Chief has retracted this article. After publication, concerns were raised about some high image similarities across publications from the same authors. Specifically:
Additionally, the Caki-2 cell line used in this article was previously misclassified as a renal clear cell line instead of renal papillary cancer cell line [3].
The authors have stated that the mistakes might have occurred in collecting western blot images for different projects. However, the authors could not provide original raw data. The Editor-in-Chief no longer has confidence in the presented data.
The Author Gianpaolo Tortora disagrees with this retraction. The Authors V Damiano, R Rosa, L Formisano, L Nappi, T Gelardi, R Marciano, I Cozzolino, G Troncone, S Agrawal, B M Veneziani, S De Placido and R Bianco did not respond to correspondence from the Publisher about this retraction notice.
References
Rosa R, Damiano V, Nappi L, Formisano L, Massari F, Scarpa A, et al. Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer. Br J Cancer. 2013;109:686–93. https://doi.org/10.1038/bjc.2013.360.
Formisano L, D'amato V, Servetto A, Brillante S, Raimondo L, Di Mauro C, et al. Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status. Oncotarget. 2015;6:26090–103. https://www.oncotarget.com/article/4636/text/.
Brodaczewska KK, Szczylik C, Fiedorowicz M, Porta C, Czarnecka AM. Choosing the right cell line for renal cell cancer research. Mol Cancer. 2016;15:83. https://doi.org/10.1186/s12943-016-0565-8.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Damiano, V., Rosa, R., Formisano, L. et al. Retraction Note: Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. Br J Cancer (2025). https://doi.org/10.1038/s41416-025-03214-y
Published:
DOI: https://doi.org/10.1038/s41416-025-03214-y